Demographics
|
|
|
Age (years)
|
54 (42–65)
|
55 (44–65)
|
Female
|
41%
|
36%
|
White race
|
88%
|
88%
|
Black race
|
8.5%
|
8.1%
|
|
|
|
General Indication for CMR exam
|
|
|
Known or suspected cardiomyopathy
|
31%
|
36%
|
Possible coronary disease (stress testing or viability)
|
31%
|
30%
|
Vasodilator stress testing
|
17%
|
17%
|
Evaluation for arrhythmia substrate
|
21%
|
25%
|
Mass or thrombus
|
3%
|
3%
|
|
|
|
Hospitalization status
|
|
|
Inpatient
|
33%
|
36%
|
|
|
|
Comorbidity
|
|
|
Hypertension
|
45%
|
51%
|
Diabetes
|
17%
|
19%
|
Dyslipidemia
|
35%
|
37%
|
Current cigarette smoking
|
15%
|
20%
|
Atrial fibrillation or flutter
|
6%
|
8%
|
Body mass index (kg/m2)
|
28.1 (24.4-33.4)
|
28.1 (24.1-33.2)
|
Obstructive coronary artery disease (>70% by angiography)
|
19%
|
20%
|
Prior coronary bypass
|
8%
|
8%
|
Prior percutaneous coronary intervention
|
14%
|
15%
|
Prior heart failure documented in medical records
|
18%
|
22%
|
Laboratory, CMR, or Echocardiography data
|
|
|
Glomerular filtration rate (mL/min/1.73 m2)
|
82 (66–102)
|
81 (66–105)
|
Ejection fraction by echocardiography (%)
|
58 (34–63)
|
58 (38–63)
|
Ejection fraction by CMR (%)
|
58 (47–65)
|
55 (38–63)
|
Late gadolinium enhancement (LGE)
|
42%
|
52%
|
Myocardial infarction by LGE |
19% |
22% |